Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Harish Manyam

Clinical Cardiac Electrophysiology Chattanooga, TN Medical Doctor

NPI 1780845032 CMS profile 307777

979 E. Third Street, Suite # C-520, Chattanooga, TN 37403

Open in the dashboard

General payments

$265,129

1,007 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,041,818 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Harish Manyam of Chattanooga, TN is reported in the CMS Open Payments database as having received $265,129 across 1,007 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,041,818 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $43,767 105
2024 General $20,529 137
2023 General $33,042 192
2022 General $51,326 178
2021 General $49,350 135
2020 General $15,929 100
2019 General $51,185 160

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Harish Manyam
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Harish Manyam were reported at $43,767. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Harish Manyam Clinical Cardiac Electrophysiology median Middle half National median
2019 $51,185 $2,361 $585–$8,260 $163
2020 $15,929 $993 $247–$4,351 $114
2021 $49,350 $1,185 $326–$4,739 $132
2022 $51,326 $2,073 $554–$6,789 $149
2023 $33,042 $2,568 $759–$8,159 $160
2024 $20,529 $2,557 $703–$7,403 $164
2025 $43,767 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $93,980 128 payments
  2. Abbott Laboratories $79,461 357 payments
  3. Philips Electronics North America Corporation $30,107 59 payments
  4. Medtronic, Inc. $25,178 130 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $13,773 21 payments
  6. Boston Scientific Corporation $9,099 53 payments
  7. E.R. Squibb & Sons, L.L.C. $3,008 27 payments
  8. Biosense Webster, Inc. $2,099 25 payments
  9. Atricure, Inc. $1,383 11 payments
  10. Novartis Pharmaceuticals Corporation $1,220 61 payments
  11. Other $5,821 135 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $113,803 47 payments
  2. Consulting Fee $78,379 32 payments
  3. Food and Beverage $31,338 846 payments
  4. Travel and Lodging $25,909 75 payments
  5. Honoraria $7,500 1 payment
  6. Compensation for serving as faculty or as a speaker for a medical education program $4,200 2 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,000 4 payments
Products named General payments · program years 2019–2025
  1. XARELTO $92,980 127 payments
  2. LifeVest $13,773 21 payments
  3. Accent Pacemaker $13,250 5 payments
  4. IGT Devices Undivided $11,617 6 payments
  5. Confirm Rx Cardiac Arrhythmias and Heart Failure $10,994 29 payments
  6. Holter $10,000 1 payment
  7. Merlin Connectivity and Remote $7,160 9 payments
  8. Fortify Assura, Ellipse ICD $6,158 5 payments
  9. Confirm Rx Cardiac Rhythm Management $6,095 29 payments
  10. Ensite Cardiac Mapping System $6,017 3 payments
  11. Other $65,514 706 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 38 drugs

Part D claims

3,282

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$997,940

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

28.9%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 419 $499,571
Eliquis Apixaban Brand 261 $303,751
Dofetilide Generic 208 $82,328
Entresto Sacubitril/Valsartan Brand 32 $43,442
Repatha Sureclick Evolocumab Brand 17 $12,822
Brilinta Ticagrelor Brand 17 $12,196
Flecainide Acetate Generic 178 $7,117
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 12 $4,708
Metoprolol Succinate Generic 189 $3,435
Mexiletine Hcl Generic 29 $3,187

The 10 drugs with the highest cost, of 38 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 87 billing codes

Paid by Medicare

$258,537

Medicare's payments for the services billed

Medicare patients

2,023

Average age 76

Services billed

5,652

1,001 women, 1,022 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 57%
Arthritis 51%
Ischemic heart disease 47%
Diabetes 39%
Heart failure 36%
Chronic kidney disease 31%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XARELTO
$12,109 419 —
Sotalol Hydrochloride
$600 66 —
VYNDAQEL
$69 — —
JARDIANCE
$62 — —
Arcalyst
$60 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

1,007 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record